FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Hill

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Phenomena

Blotting, Western

Anatomy

Physiology

Protein Folding

Co-author Network

Publications

TOP 3
Shayne A Bellingham; Bradley M Coleman; Andrew Hill
Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells.
Bradley M Coleman; Eric Hanssen; Victoria A Lawson; Andrew Hill
Prion-infected cells regulate the release of exosomes with distinct ultrastructural features.
Shayne A Bellingham; Bradley M Coleman; Belinda B Guo; Andrew Hill
Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Hill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Shayne A Bellingham; Bradley M Coleman; Andrew Hill
Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells.
Nucleic acids research 2012;40(21):10937-49.
2012: Bradley M Coleman; Eric Hanssen; Victoria A Lawson; Andrew Hill
Prion-infected cells regulate the release of exosomes with distinct ultrastructural features.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(10):4160-73.
2012: Shayne A Bellingham; Bradley M Coleman; Belinda B Guo; Andrew Hill
Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?
Frontiers in physiology 2012;3():124.
2011: Claudia Santosa; Stefanie Rasche; Adel Barakat; Shayne A Bellingham; Michael Ho; Jiangli Tan; Andrew Hill; Colin L Masters; Catriona McLean; Geneviève Evin
Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein.
Neurobiology of disease 2011;43(1):176-83.
2010: Li Hongyun; Woojin S Kim; Gilles J Guillemin; Andrew Hill; Genevieve Evin; Brett Garner
Modulation of amyloid precursor protein processing by synthetic ceramide analogues.
Biochimica et biophysica acta 2010;1801(8):887-95.
2010: Marcus Brazier; Irene Volitakis; Magda Kvasnicka; Anthony R White; John R Underwood; Jason E Green; Sen Han; Andrew Hill; Colin L Masters; Steven J Collins
Manganese chelation therapy extends survival in a mouse model of M1000 prion disease.
Journal of neurochemistry 2010;114(2):440-51.
2010: Rebecca M Nisbet; Christopher F Harrison; Victoria A Lawson; Colin L Masters; Roberto Cappai; Andrew Hill
Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease.
Journal of virology 2010;84(13):6678-86.
2010: Christopher F Harrison; Victoria A Lawson; Bradley M Coleman; Yong-Sun Kim; Colin L Masters; Roberto Cappai; Kevin J Barnham; Andrew Hill
Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.
The Journal of biological chemistry 2010;285(26):20213-23.
2010: Victoria M Perreau; Sandra Orchard; Paul A Adlard; Shayne A Bellingham; Roberto Cappai; Giuseppe D Ciccotosto; Tiffany F Cowie; Peter J Crouch; James A Duce; Geneviève Evin; Noel G Faux; Andrew Hill; Ya Hui Hung; Simon A James; Qiao-Xin Li; Su San Mok; Deborah J Tew; Anthony R White; Ashley I Bush; Henning Hermjakob; Colin L Masters
A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer's disease.
Proteomics 2010;10(12):2377-95.
2010: Catherine A Tabrett; Christopher F Harrison; Bryan Schmidt; Shayne A Bellingham; Tristan Hardy; Yves-Henri Sanejouand; Andrew Hill; Philip J Hogg
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
The Biochemical journal 2010;428(2):169-82.
2010: Yasmin M Ramdzan; Rebecca M Nisbet; Jason Miller; Steven Finkbeiner; Andrew Hill; Danny M Hatters
Conformation sensors that distinguish monomeric proteins from oligomers in live cells.
Chemistry & biology 2010;17(4):371-9.
2010: Victoria A Lawson; Brooke Lumicisi; Jeremy Welton; Dorothy Machalek; Katrina Gouramanis; Helen M Klemm; James D Stewart; Colin L Masters; David E Hoke; Steven J Collins; Andrew Hill
Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.
PloS one 2010;5(8):e12351.
2009: Victoria Lewis; Andrew Hill; Cathryn L Haigh; Genevieve M Klug; Colin L Masters; Victoria A Lawson; Steven J Collins
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
Journal of neuropathology and experimental neurology 2009;68(10):1125-35.
2009: Cathryn L Haigh; Victoria A Lewis; Laura J Vella; Colin L Masters; Andrew Hill; Victoria A Lawson; Steven J Collins
PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site.
Cell research 2009;19(9):1062-78.
2009: Su Ling Leong; Chi L L Pham; Denise Galatis; Michelle T Fodero-Tavoletti; Keyla Perez; Andrew Hill; Colin L Masters; Feda E Ali; Kevin J Barnham; Roberto Cappai
Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
Free radical biology & medicine 2009;46(10):1328-37.
2009: Chi L L Pham; Su Ling Leong; Feda E Ali; Vijaya Kenche; Andrew Hill; Sally L Gras; Kevin J Barnham; Roberto Cappai
Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
Journal of molecular biology 2009;387(3):771-85.
2009: Bradley M Coleman; Rebecca M Nisbet; Sen Han; Roberto Cappai; Danny M Hatters; Andrew Hill
Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Biochemical and biophysical research communications 2009;380(3):564-8.
2009: Shayne A Bellingham; Louise A Coleman; Colin L Masters; James Camakaris; Andrew Hill
Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1.
The Journal of biological chemistry 2009;284(2):1291-301.
2009: Woojin Scott Kim; Sharon L Chan; Andrew Hill; Gilles GUILLEMIN; Brett Garner
Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons.
Journal of Alzheimer's disease : JAD 2009;16(1):121-31.
2008: R Naylor; Andrew Hill; Kevin J Barnham
Is covalently crosslinked Abeta responsible for synaptotoxicity in Alzheimer's disease?
Current Alzheimer research 2008;5(6):533-9.
2008: John Collinge; Jerome Whitfield; Edward McKintosh; Adam Frosh; simon mead; Andrew Hill; Sebastian Brandner; Dafydd Thomas; Michael P Alpers
A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2008;363(1510):3725-39.
2008: Laura J Vella; Deanne L V Greenwood; Roberto Cappai; Jean-Pierre Y Scheerlinck; Andrew Hill
Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid.
Veterinary immunology and immunopathology 2008;124(3-4):385-93.
2008: Sharon L Chan; Woojin Scott Kim; John B J Kwok; Andrew Hill; Roberto Cappai; Kerry-Anne Rye; Brett Garner
ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro.
Journal of neurochemistry 2008;106(2):793-804.
2008: Valeria Albanese; Victoria A Lawson; Andrew Hill; Roberto Cappai; Giovanni Di Guardo; Vasiliki Staikopoulos; Michelle Thacker; John B Furness; Roberto Chiocchetti
Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine.
Autonomic neuroscience : basic & clinical 2008;140(1-2):17-23.
2008: Robyn A Sharples; Laura J Vella; Rebecca M Nisbet; Ryan Naylor; Keyla Perez; Kevin J Barnham; Colin L Masters; Andrew Hill
Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(5):1469-78.
2008: Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; simon mead; Sebastian Brandner; Andrew Hill; John Collinge
Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(10):3885-90.
2008: Ryan Naylor; Andrew Hill; Kevin J Barnham
Neurotoxicity in Alzheimer's disease: is covalently crosslinked A beta responsible?
European biophysics journal : EBJ 2008;37(3):265-8.
2008: Laura J Vella; Robyn A Sharples; Rebecca M Nisbet; Roberto Cappai; Andrew Hill
The role of exosomes in the processing of proteins associated with neurodegenerative diseases.
European biophysics journal : EBJ 2008;37(3):323-32.
2008: Paul S Donnelly; Aphrodite Caragounis; Tai Du; Katrina M Laughton; Irene Volitakis; Robert A Cherny; Robyn A Sharples; Andrew Hill; Qiao-Xin Li; Colin L Masters; Kevin J Barnham; Anthony R White
Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide.
The Journal of biological chemistry 2008;283(8):4568-77.
2008: David P Smith; Deborah J Tew; Andrew Hill; Stephen P Bottomley; Colin L Masters; Kevin J Barnham; Roberto Cappai
Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.
Biochemistry 2008;47(5):1425-34.
2008: Victoria A Lawson; Laura J Vella; James D Stewart; Robyn A Sharples; Helen Klemm; Dorothy M Machalek; Colin L Masters; Roberto Cappai; Steven J Collins; Andrew Hill
Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
The international journal of biochemistry & cell biology 2008;40(12):2793-801.
2008: Victoria Lewis; Genevieve M Klug; Andrew Hill; Steven J Collins
Molecular typing of PrPres in human sporadic CJD brain tissue.
Methods in molecular biology (Clifton, N.J.) 2008;459():241-7.
2008: Sen Han; Andrew Hill
Analysis of PrP conformation using circular dichroism.
Methods in molecular biology (Clifton, N.J.) 2008;459():145-59.
2008: Laura J Vella; Andrew Hill
Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.
Methods in molecular biology (Clifton, N.J.) 2008;459():69-82.
2008: Katherine A Price; Gulay Filiz; Aphrodite Caragounis; Tai Du; Katrina M Laughton; Colin L Masters; Robyn A Sharples; Andrew Hill; Qiao-Xin Li; Paul S Donnelly; Kevin J Barnham; Peter J Crouch; Anthony R White
Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide.
The international journal of biochemistry & cell biology 2008;40(9):1901-17.
2008: Marie-Pierre Courageot; Nathalie Daude; Romolo Nonno; Sophie Paquet; Michele Angelo Di Bari; Annick Le Dur; Jérome Chapuis; Andrew Hill; Umberto Agrimi; Hubert Laude; Didier Vilette
A cell line infectible by prion strains from different species.
The Journal of general virology 2008;89(Pt 1):341-7.
2007: Christopher F Harrison; Kevin J Barnham; Andrew Hill
Neurotoxic species in prion disease: a role for PrP isoforms?
Journal of neurochemistry 2007;103(5):1709-20.
2007: Aphrodite Caragounis; Tai Du; Gulay Filiz; Katrina M Laughton; Irene Volitakis; Robyn A Sharples; Robert A Cherny; Colin L Masters; Simon C Drew; Andrew Hill; Qiao-Xin Li; Peter J Crouch; Kevin J Barnham; Anthony R White
Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.
The Biochemical journal 2007;407(3):435-50.
2007: L J Vella; Robyn A Sharples; Victoria A Lawson; Colin L Masters; Roberto Cappai; Andrew Hill
Packaging of prions into exosomes is associated with a novel pathway of PrP processing.
The Journal of pathology 2007;211(5):582-90.
2007: Woojin Scott Kim; Aldwin Suryo Rahmanto; Alvin Kamili; Kerry-Anne Rye; Gilles GUILLEMIN; Ingrid Gelissen; Wendy Jessup; Andrew Hill; Brett Garner
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation.
The Journal of biological chemistry 2007;282(5):2851-61.
2006: Chou Hung Sim; Daisy Sio Seng Lio; Su San Mok; Colin L Masters; Andrew Hill; Janetta G Culvenor; Heung-Chin Cheng
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
Human molecular genetics 2006;15(21):3251-62.
2006: Kevin J Barnham; Roberto Cappai; Konrad Beyreuther; Colin L Masters; Andrew Hill
Delineating common molecular mechanisms in Alzheimer's and prion diseases.
Trends in biochemical sciences 2006;31(8):465-72.
2006: Anthony R White; Tai Du; Katrina M Laughton; Irene Volitakis; Robyn A Sharples; Michel E Xilinas; David E Hoke; R. M. Damian Holsinger; Geneviève Evin; Robert A Cherny; Andrew Hill; Kevin J Barnham; Qiao-Xin Li; Ashley I Bush; Colin L Masters
Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity.
The Journal of biological chemistry 2006;281(26):17670-80.
2006: Leanne M Wilson; Chi L L Pham; Alicia J Jenkins; John D Wade; Andrew Hill; Matthew A Perugini; Geoffrey J Howlett
High density lipoproteins bind Abeta and apolipoprotein C-II amyloid fibrils.
Journal of lipid research 2006;47(4):755-60.
2006: Andrew Hill; Susan Joiner; Jonathan A Beck; Tracy A Campbell; Andrew Dickinson; Mark Poulter; Jonathan D F Wadsworth; John Collinge
Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations.
Brain : a journal of neurology 2006;129(Pt 3):676-85.
2006: Marcus Brazier; Victoria Lewis; Giuseppe D Ciccotosto; Genevieve M Klug; Victoria A Lawson; Roberto Cappai; James W Ironside; Colin L Masters; Andrew Hill; Anthony R White; Steven Collins
Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.
Brain research bulletin 2006;68(5):346-54.
2005: Fang F Yuan; Sandra Biffin; Marcus Brazier; Monica Suarez; Roberto Cappai; Andrew Hill; Steven J Collins; John Sullivan; Deborah Middleton; Gerd Multhaup; Andrew F Geczy; Colin L Masters
Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Immunology and cell biology 2005;83(6):632-7.
2005: Steven J Collins; Victoria Lewis; Marcus Brazier; Andrew Hill; Victoria A Lawson; Genevieve M Klug; Colin L Masters
Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control.
Neurobiology of disease 2005;20(2):336-46.
2005: Roberto Cappai; Su-Ling Leck; Deborah J Tew; Nicholas A Williamson; David P Smith; Denise Galatis; Robyn A Sharples; Cyril C Curtain; Feda E Ali; Robert A Cherny; Janetta G Culvenor; Stephen P Bottomley; Colin L Masters; Kevin J Barnham; Andrew Hill
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(10):1377-9.
2005: Victoria Lewis; Andrew Hill; Genevieve M Klug; Alison Boyd; Colin L Masters; Steven J Collins
Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
Neurology 2005;65(1):113-8.
2005: Victoria A Lawson; Steven J Collins; Colin L Masters; Andrew Hill
Prion protein glycosylation.
Journal of neurochemistry 2005;93(4):793-801.
2005: Bradley J Turner; Julie D Atkin; Manal A Farg; Da Wei Zang; Alan Rembach; Elizabeth C Lopes; Justin D Patch; Andrew Hill; Surindar S Cheema
Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(1):108-17.
2004: Jonathan D F Wadsworth; Emmanuel A Asante; Melanie Desbruslais; Jacqueline M Linehan; Susan Joiner; Ian Gowland; Julie Welch; Lisa Stone; Sarah E Lloyd; Andrew Hill; Sebastian Brandner; John Collinge
Human prion protein with valine 129 prevents expression of variant CJD phenotype.
Science (New York, N.Y.) 2004;306(5702):1793-6.
2004: Andrew Hill
Identification of a new prion strain in cattle--is there more than one form of BSE?
Australian veterinary journal 2004;82(5):288-91.
2004: Andrew Hill; John Collinge
Prion strains and species barriers.
Contributions to microbiology 2004;11():33-49.
2003: Andrew Hill; John Collinge
Subclinical prion infection.
Trends in microbiology 2003;11(12):578-84.
2003: Janelle Nunan; Nicholas A Williamson; Andrew Hill; M Fleur Sernee; Colin L Masters; David Small
Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
Journal of neuroscience research 2003;74(3):378-85.
2003: Andrew Hill; Susan Joiner; Jonathan D F Wadsworth; Katie C L Sidle; Jeanne E Bell; Herbert Budka; James W Ironside; John Collinge
Molecular classification of sporadic Creutzfeldt-Jakob disease.
Brain : a journal of neurology 2003;126(Pt 6):1333-46.
2003: Victoria Lewis; Steven Collins; Andrew Hill; Alison Boyd; Catriona A McLean; M Smith; Colin L Masters
Novel prion protein insert mutation associated with prolonged neurodegenerative illness.
Neurology 2003;60(10):1620-4.
2003: Andrew Hill
Possible link between bovine spongiform encephalopathy and sporadic Creutzfeldt-Jakob disease.
Australian veterinary journal 2003;81(5):275-6.
2003: Jonathan D F Wadsworth; Andrew Hill; Jonathan A Beck; John Collinge
Molecular and clinical classification of human prion disease.
British medical bulletin 2003;66():241-54.
2003: Andrew Hill; John Collinge
Subclinical prion infection in humans and animals.
British medical bulletin 2003;66():161-70.
2002: Emmanuel A Asante; Jacqueline M Linehan; Melanie Desbruslais; Susan Joiner; Ian Gowland; Andrew L Wood; Julie Welch; Andrew Hill; Sarah E Lloyd; Jonathan D F Wadsworth; John Collinge
BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.
The EMBO journal 2002;21(23):6358-66.
2002: Steven J Collins; Victoria Lewis; Marcus Brazier; Andrew Hill; Ashley Fletcher; Colin L Masters
Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model.
Annals of neurology 2002;52(4):503-6.
2002: Steven Collins; Alison Boyd; Ashley Fletcher; John Kaldor; Andrew Hill; Stephen Farish; Catriona McLean; Zahid Ansari; Margaret Smith; Colin L Masters
Creutzfeldt-Jakob disease cluster in an Australian rural city.
Annals of neurology 2002;52(1):115-8.
2002: Andrew Hill; John Collinge
Species-barrier-independent prion replication in apparently resistant species.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(1):44-53.
2001: Jonathan D F Wadsworth; Susan Joiner; Andrew Hill; Tracy A Campbell; Melanie Desbruslais; P J Luthert; John Collinge
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.
Lancet 2001;358(9277):171-80.
2001: Anthony R White; R Guirguis; Marcus Brazier; Michael F Jobling; Andrew Hill; Konrad Beyreuther; Colin J Barrow; Colin L Masters; Steven J Collins; Roberto Cappai
Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
Neurobiology of disease 2001;8(2):299-316.
2001: Andrew Hill; John Collinge
Strain variations and species barriers.
Contributions to microbiology 2001;7():48-57.
2000: Andrew Hill; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; P L Lantos; John Collinge
Species-barrier-independent prion replication in apparently resistant species.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(18):10248-53.
1999: Jonathan D F Wadsworth; Graham S Jackson; Andrew Hill; John Collinge
Molecular biology of prion propagation.
Current opinion in genetics & development 1999;9(3):338-45.
1999: Jonathan D F Wadsworth; Andrew Hill; Susan Joiner; Graham S Jackson; Anthony R Clarke; John Collinge
Strain-specific prion-protein conformation determined by metal ions.
Nature cell biology 1999;1(1):55-9.
1999: Graham S Jackson; Andrew Hill; C Joseph; Laszlo L P Hosszu; A Power; Jonathan P Waltho; Anthony R Clarke; John Collinge
Multiple folding pathways for heterologously expressed human prion protein.
Biochimica et biophysica acta 1999;1431(1):1-13.
1999: Graham S Jackson; Laszlo L P Hosszu; A Power; Andrew Hill; J Kenney; Helen R Saibil; C Jeremy Craven; Jonathan P Waltho; Anthony R Clarke; John Collinge
Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
Science (New York, N.Y.) 1999;283(5409):1935-7.
1999: Andrew Hill; R J Butterworth; Susan Joiner; G Jackson; Martin N Rossor; D J Thomas; AC Frosh; Neil Samuel Tolley; J E Bell; M Spencer; A King; Safa Al-Sarraj; James W Ironside; P L Lantos; John Collinge
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.
Lancet 1999;353(9148):183-9.
1999: Andrew Hill; M Antoniou; John Collinge
Protease-resistant prion protein produced in vitro lacks detectable infectivity.
The Journal of general virology 1999;80 ( Pt 1)():11-4.
1998: Andrew Hill; Katie C L Sidle; Susan Joiner; P Keyes; T C Martin; M Dawson; John Collinge
Molecular screening of sheep for bovine spongiform encephalopathy.
Neuroscience letters 1998;255(3):159-62.
1998: Pedro Piccardo; J P Langeveld; Andrew Hill; Stephen R Dlouhy; K Young; G Giaccone; G Rossi; M Bugiani; Orso Bugiani; R H Meloen; J Collinge; Fabrizio Tagliavini; Bernardino Ghetti
An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.
The American journal of pathology 1998;152(6):1415-20.
1997: Andrew Hill; Melanie Desbruslais; Susan Joiner; Katie C L Sidle; Ian Gowland; John Collinge; LJ Doey; Peter Lantos
The same prion strain causes vCJD and BSE.
Nature 1997;389(6650):448-50, 526.
1997: Andrew Hill; R G Will; J Ironside; John Collinge
Type of prion protein in UK farmers with Creutzfeldt-Jakob disease.
Lancet 1997;350(9072):188.
1997: Andrew Hill; M Zeidler; J Ironside; John Collinge
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.
Lancet 1997;349(9045):99-100.
1996: John Collinge; K C Sidle; J Meads; J Ironside; Andrew Hill
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.
Nature 1996;383(6602):685-90.
1995: John Collinge; M S Palmer; K C Sidle; Andrew Hill; I Gowland; J Meads; E Asante; R Bradley; L J Doey; P L Lantos
Unaltered susceptibility to BSE in transgenic mice expressing human prion protein.
Nature 1995;378(6559):779-83.
1995: Miles A Whittington; K C Sidle; I Gowland; J Meads; Andrew Hill; M S Palmer; John Jefferys; John Collinge
Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein.
Nature genetics 1995;9(2):197-201.
1993: M S Palmer; S P Mahal; Tracy A Campbell; Andrew Hill; K C Sidle; J L Laplanche; John Collinge
Deletions in the prion protein gene are not associated with CJD.
Human molecular genetics 1993;2(5):541-4.